Text Correction
There was an error in the original publication [1]. The following sentence “The oncogenic activation of Abl1 in BCR-ABL1 chimeric proteins is mediated by an N-terminal coiled-coil (CC) oligomerization-dependent mechanism [226].” has been revised and replaced by the following sentence, “The oncogenic activation of Abl1 in BCR-ABL1 chimeric proteins is indeed mediated by an N-terminal coiled-coil (CC) domain, which acts as an oligomerization-dependent mechanism to trigger constitutive kinase activity [231,232]”.
The following sentence “The oncogenic activity of Abl1 in the context of the ABL1-BCR fusion protein is mediated via the BCR N-terminal coiled-coil (CC) oligomerization domain [208,239,240]” has been replaced by the following, “The oncogenic activity of the BCR-ABL1 fusion protein is primarily mediated through the N-terminal coiled-coil (CC) oligomerization domain of the BCR portion, which brings multiple ABL1 kinase domains into close proximity, leading to constitutive tyrosine kinase activation [241,242]” together with the supported references.
Extra Citation
The following reference should be removed:
Luttman, J.H.; Colemon, A.; Mayro, B.; Pendergast, A.M. Role of the ABL tyrosine kinases in the epithelial-mesenchymal transition and the metastatic cascade. Cell Commun. Signal. 2021, 19, 59.
Missing Citation
The newly added references appear below:
- 231.
- Beissert, T.; Puccetti, E.; Bianchini, A.; Güller, S.; Boehrer, S.; Hoelzer, D.; Ottmann, O.G.; Nervi, C.; Ruthardt, M. Targeting of the N-terminal coiled coil oligomerization interface of BCR interferes with the transformation potential of BCR-ABL and increases sensitivity to STI571. Blood 2003, 102, 2985–2993.
- 232.
- Massimino, M.; Stella, S.; Romano, C.; Buffa, P.; Tirrò, E.; Drago, M.; Manzella, L.; Tomarchio, C.; Vitale, S.R.; Raimondo, F.D.; et al. The Coiled Coil and C2 Domains Modulate BCR Localization and BCR-ABL1 Compartmentalization, Transforming Activity and TKI Responsiveness. Int. J. Mol. Sci. 2025, 26, 6591.
- 241.
- Shammas, T.; Peiris, M.N.; Meyer, A.N.; Donoghue, D.J. BCR-ABL: The molecular mastermind behind chronic myeloid leukemia. Cytokine Growth Factor Rev. 2025, 83, 45–58.
- 242.
- Peiris, M.N.; Li, F.; Donoghue, D.J. BCR: A promiscuous fusion partner in hematopoietic disorders. Oncotarget 2019, 10, 2738–2754.
With this correction, the order of some references has been adjusted accordingly. The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Reference
- Eshaq, A.M.; Flanagan, T.W.; Hassan, S.-Y.; Al Asheikh, S.A.; Al-Amoudi, W.A.; Santourlidis, S.; Hassan, S.-L.; Alamodi, M.O.; Bendhack, M.L.; Alamodi, M.O.; et al. Non-Receptor Tyrosine Kinases: Their Structure and Mechanistic Role in Tumor Progression and Resistance. Cancers 2024, 16, 2754. [Google Scholar] [CrossRef] [Scilit] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.